Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Muscular Dystrophy, Duchenne: full-pipeline trial registry
1 of 5 indexed Muscular Dystrophy, Duchenne trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Muscular Dystrophy, Duchenne: 5 US clinical trials tracked, 1 recruiting.
Muscular Dystrophy, Duchenne is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Sarepta Therapeutics, running 3 of these trials.
Enrollment posture brief
Registry condition muscular-dystrophy-duchenne
OPEN 1 | RECR 20% | LATE 3 | EARLY 2 | RANK #3391 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Muscular Dystrophy, Duchenne lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Muscular Dystrophy, Duchenne on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Muscular Dystrophy, Duchenne is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Muscular Dystrophy, Duchenne research.
Sarepta Therapeutics accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.
-
Most Muscular Dystrophy, Duchenne trials plan to enrol fewer than 100 people.
Median target enrolment is 83 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.
-
Muscular Dystrophy, Duchenne research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
Sarepta Therapeutics
NCT04626674
A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)
Sarepta Therapeutics
NCT03992430
A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
Capricor
NCT05126758
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
Santhera Pharmaceuticals
NCT01027884
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of SRP-5051 (Vesleteplirsen) in Patients With Duchenne Muscular Dystrophy (DMD)
Sarepta Therapeutics
NCT03375255
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Muscular Dystrophy, Duchenne records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Muscular Dystrophy, Duchenne trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Muscular Dystrophy, Duchenne page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Muscular Dystrophy, Duchenne trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Sarepta Therapeutics sponsors the most Muscular Dystrophy, Duchenne trials on record, review their full trial history before evaluating a specific study. See Sarepta Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Muscular Dystrophy, Duchenne condition card totals 5 registered trials; most-linked intervention SRP-5051; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.